# A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.

> **NCT01408355** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 5 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PF-06273588
- **DRUG:** PF-06273588

## Key facts

- **NCT ID:** NCT01408355
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2011-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408355, "A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01408355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*